Shuttle Pharmaceuticals issues 3,737,482 shares in unregistered sale after preferred conversions

PUBT · 2d ago
Shuttle Pharmaceuticals issues 3,737,482 shares in unregistered sale after preferred conversions
  • Shuttle Pharmaceuticals issued 3,737,482 common shares via conversions of Series B-1 and Series B-2 preferred stock as of Sept. 14, 2026.
  • Separately issued warrants as of Sept. 9, 2026, covering about 927,114 shares at an exercise price of $10.3.
  • Also issued pre-funded warrants covering about 16,932,508 shares.
  • Transaction relied on the Securities Act Section 4(a)(2) exemption for unregistered sales.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-042791), on September 16, 2026, and is solely responsible for the information contained therein.